FDA Approves Renal Denervation for High Blood Pressure

U.S. physicians finally have a new option for treating high blood pressure (hypertension) that remains inadequately controlled despite medication and lifestyle changes.

FDA approved the Recor Medical's Paradise ultrasound renal denervation (RDN) system. The Palo Alto, CA-based company's RDN system is designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.